What's the best way to taper diazepam?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diazepam Tapering Protocol

For diazepam tapering, reduce the dose by 10-25% of the current dose (not the original dose) every 1-2 weeks, slowing to 10% per month for patients on benzodiazepines longer than 1 year, with the understanding that the taper will likely take 6-12 months minimum and possibly much longer. 1

Core Tapering Principles

The reduction must be calculated as a percentage of the current dose, not the original starting dose. 1 This is a critical distinction that prevents disproportionately large reductions as you approach lower doses. For example, if a patient starts at 20 mg/day:

  • Week 1-2: Reduce to 15 mg/day (25% reduction of current 20 mg dose) 1
  • Week 3-4: Reduce to 11-12 mg/day (20-25% of current 15 mg dose) 1
  • Continue reducing by 10-25% of the current dose every 1-2 weeks 1

For patients who have been taking benzodiazepines for more than 1 year, extend the taper to 10% per month rather than 10-25% every 1-2 weeks. 1 Long-term users require slower tapers because they have developed more significant physiological dependence. 1

Determining Your Taper Rate

The taper rate must be determined by the patient's ability to tolerate reductions, not by a rigid schedule. 1 Pauses in the taper are acceptable and often necessary when withdrawal symptoms emerge. 1 This is not a failure—maintaining patient comfort and function is paramount. 1

If withdrawal symptoms become severe, return to the previous well-tolerated dose and slow the taper further. 1 Never push through intolerable symptoms, as this leads to taper failure and patient abandonment of the process. 1

Monitoring Requirements

Follow up at least monthly during the taper, with more frequent contact needed during difficult phases. 1 At each visit, monitor for:

  • Withdrawal symptoms: anxiety, tremor, insomnia, sweating, tachycardia, headache, weakness, muscle aches, nausea, confusion 1
  • Mood changes and suicidal ideation 1
  • Screen for depression, anxiety, and substance use disorders that may emerge during tapering 1

Managing Withdrawal Symptoms

Integrate cognitive behavioral therapy (CBT) during the taper, as this significantly increases success rates. 1 Additional supportive measures include mindfulness and relaxation techniques, sleep hygiene education, and exercise training. 1

Consider adjunctive medications for specific withdrawal symptoms:

  • Gabapentin for anxiety and irritability: Start 100-300 mg at bedtime or three times daily, increase by 100-300 mg every 1-7 days as tolerated 1
  • Clonidine or tizanidine for autonomic symptoms (sweating, tachycardia) 2
  • Trazodone for insomnia 2
  • Carbamazepine may help mitigate withdrawal symptoms, particularly for patients on ≥20 mg/day diazepam equivalents 1, 3

Critical Safety Considerations

Abrupt discontinuation of diazepam can cause seizures and death and is never appropriate. 1, 4 The FDA explicitly warns that gradual tapering is required to reduce the risk of withdrawal reactions. 4

If a patient develops withdrawal reactions, pause the taper or increase the dosage to the previous tapered dosage level, then decrease more slowly. 4 This is standard FDA guidance and should be followed rigorously.

Advise patients of increased overdose risk if they return to previous doses after tolerance is lost. 1 Once physiological dependence has decreased through tapering, returning to the original dose can cause respiratory depression and death. 1

Special Populations

Pregnant patients should not taper benzodiazepines during pregnancy without specialist consultation, as withdrawal can cause spontaneous abortion and premature labor. 1 This is an absolute contraindication to unsupervised tapering. 1

Elderly patients require more gradual tapers with smaller dose reductions to minimize adverse effects. 1 Benzodiazepines in elderly patients are associated with cognitive impairment, falls, fractures, and loss of functional independence. 1

When to Refer to a Specialist

Refer immediately if the patient has:

  • History of withdrawal seizures 1
  • Unstable psychiatric comorbidities 1
  • Co-occurring substance use disorders 1
  • Previous unsuccessful office-based tapering attempts 1

Realistic Timeline and Expectations

The taper will likely take 6-12 months minimum, and possibly longer. 1 For patients on diazepam for years, the taper may take 1-2 years or more. 1 Some patients may benefit from maintenance at a reduced dose rather than complete discontinuation—the target dose does not need to be zero. 2

Tapers may be considered successful as long as the patient is making progress. 5 Once the smallest available dose is reached (typically 2 mg), the interval between doses can be extended before complete discontinuation. 5

Key Pitfalls to Avoid

Never taper too quickly. 1 Research shows that even a 10% reduction every 3 days resulted in only 24% of patients completing withdrawal successfully. 1

Never abandon the patient who is struggling with the taper. 1 Consider pausing rather than discontinuing care. 1 Patient agreement and interest in tapering is a key component of success. 1

Never set arbitrary time limits for completing the taper. 1 The goal is durability of the taper, not speed. 2

Concurrent Opioid Use

If a patient is taking both opioids and benzodiazepines and both need to be discontinued, reduce the benzodiazepines first due to the higher risks associated with their withdrawal. 1 Benzodiazepine withdrawal carries greater risks than opioid withdrawal, including seizures and death. 1

References

Guideline

Benzodiazepine Discontinuation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Lorazepam Tapering Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.